Chugai Pharmaceutical Co. Ltd. - Begin Period Cashflow

Chugai Pharmaceutical Co. Ltd.'s Fiscal Year is From January To December - All Figures are in JPY, Trillions.

The item "Begin-Period-Cashflow" stands at 1.86 Trillion Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025, the highest value at least since 03/31/2012, the period currently displayed.

Chugai Pharmaceutical Co. Ltd.'s third quarter result of 0.4971 Trillion JPY for the item "Begin Period Cashflow" represents an increase of 17.40 percent compared to it's second quarter result.

Also, Chugai Pharmaceutical Co. Ltd.'s third quarter result of 0.4971 Trillion JPY for the item "Begin Period Cashflow" represents an increase of 26.24 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), Chugai Pharmaceutical Co. Ltd.'s third quarter result of 1.86 Trillion JPY for the item "Begin Period Cashflow" represents an increase of 5.87 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 13.24 percent compared to the value the year prior.
The 1 year change in percent is 13.24.
The 3 year change in percent is 77.41.
The 5 year change in percent is 160.33.
The 10 year change in percent is 294.71.

The Serie's long term average value is 0.732 Trillion Japanese Yens. It's latest available value, on 09/30/2025, is 154.78 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2011, to it's latest available value, on 09/30/2025, is +421.56%.
The Serie's change in percent from it's maximum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is 0.0%.